Nazeer Hasan

ORCID: 0000-0002-0785-1735
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advancements in Transdermal Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Advanced Drug Delivery Systems
  • RNA Interference and Gene Delivery
  • Nanoplatforms for cancer theranostics
  • Immunotherapy and Immune Responses
  • Lipid Membrane Structure and Behavior
  • Toxin Mechanisms and Immunotoxins
  • Drug Solubulity and Delivery Systems
  • Cannabis and Cannabinoid Research
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Phytochemicals and Antioxidant Activities
  • Electrospun Nanofibers in Biomedical Applications
  • Graphene and Nanomaterials Applications
  • Conducting polymers and applications
  • Drug Transport and Resistance Mechanisms
  • Dental Implant Techniques and Outcomes
  • Fatty Acid Research and Health
  • Chronic Myeloid Leukemia Treatments
  • Proteins in Food Systems
  • Pomegranate: compositions and health benefits
  • Carbon and Quantum Dots Applications
  • Quinazolinone synthesis and applications
  • Transgenic Plants and Applications
  • Dendrimers and Hyperbranched Polymers

Jamia Hamdard
2017-2025

Hamdard University
2022

Ministry of Defence
2021

Defence Research and Development Organisation
2021

Delhi Pharmaceutical Science and Research University
2021

Institute of Nuclear Medicine & Allied Sciences
2021

Cerium oxide nanoparticles (CNPs), owing to their antioxidant property, have recently emerged as therapeutic candidate for Alzheimer's disease (AD). However, intravenous CNPs are limited due poor physicochemical properties, rapid blood clearance and blood-brain penetration. Thus, we developed intranasal evaluated its potential in experimental AD. were synthesized using homogenous precipitation method optimized through Box-Behnken Design. The formation of was confirmed by UV spectroscopy...

10.3390/pharmaceutics14040756 article EN cc-by Pharmaceutics 2022-03-30

Abstract: Cancer is a group of dynamic diseases characterized by uncontrollable growth and spread cells. The heterogenic nature cancer hinders the abolishment resulting in narrow therapeutic index, capacity drug efflux, multidrug resistance, unacceptable side effects. major challenge treatment malignancies resistance (MDR). A novel platform, nanoscale delivery system, concluding desirable applications for with targeted controlled release drugs, reducing number effects systemic toxicity....

10.2174/0115672018341670241124150932 article EN Current Drug Delivery 2025-01-15

Skin cancer is one of the most lethal cancers today, posing significant challenges to public health and potentially impacting global economic stability. Due its high rate incidence, innovative effective treatments are crucial. Among these, immunothera-peutic approaches have emerged as transformative, offering new hope by harnessing body’s immune system target eliminate cancerous cells. Immunotherapy has changed treatment landscape for skin cancer, providing options such checkpoint inhibitors...

10.2174/0115680096349248250113093025 article EN Current Cancer Drug Targets 2025-02-12
Coming Soon ...